209 related articles for article (PubMed ID: 29116504)
21. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
[TBL] [Abstract][Full Text] [Related]
22. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
23. The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.
Feige MJ; Gräwert MA; Marcinowski M; Hennig J; Behnke J; Ausländer D; Herold EM; Peschek J; Castro CD; Flajnik M; Hendershot LM; Sattler M; Groll M; Buchner J
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8155-60. PubMed ID: 24830426
[TBL] [Abstract][Full Text] [Related]
24. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
Front Immunol; 2022; 13():953917. PubMed ID: 36177031
[TBL] [Abstract][Full Text] [Related]
25. [Progress in shark single-domain antibody].
Liu X; Chen Q
Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058
[TBL] [Abstract][Full Text] [Related]
26. Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.
Kovaleva M; Ferguson L; Steven J; Porter A; Barelle C
Expert Opin Biol Ther; 2014 Oct; 14(10):1527-39. PubMed ID: 25090369
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody.
Cheong WS; Leow CY; Abdul Majeed AB; Leow CH
Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922
[TBL] [Abstract][Full Text] [Related]
28. The generation and selection of single-domain, v region libraries from nurse sharks.
Flajnik MF; Dooley H
Methods Mol Biol; 2009; 562():71-82. PubMed ID: 19554288
[TBL] [Abstract][Full Text] [Related]
29. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
Jiang X; Sun S; Li Z; Chen M
Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
[TBL] [Abstract][Full Text] [Related]
30. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
Front Immunol; 2020; 11():560244. PubMed ID: 33324393
[TBL] [Abstract][Full Text] [Related]
31. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
32. Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development.
Diaz M; Stanfield RL; Greenberg AS; Flajnik MF
Immunogenetics; 2002 Oct; 54(7):501-12. PubMed ID: 12389098
[TBL] [Abstract][Full Text] [Related]
33. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
34. Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries.
Nuttall SD; Krishnan UV; Hattarki M; De Gori R; Irving RA; Hudson PJ
Mol Immunol; 2001 Aug; 38(4):313-26. PubMed ID: 11566324
[TBL] [Abstract][Full Text] [Related]
35. IgNAR characterization and gene loci identification in whitespotted bamboo shark (Chiloscyllium plagiosum) genome.
Jia L; Wang Y; Shen Y; Zhong B; Luo Z; Yang J; Chen G; Jiang X; Chen J; Lyu Z
Fish Shellfish Immunol; 2023 Feb; 133():108535. PubMed ID: 36649810
[TBL] [Abstract][Full Text] [Related]
36. First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate.
Dooley H; Stanfield RL; Brady RA; Flajnik MF
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1846-51. PubMed ID: 16446445
[TBL] [Abstract][Full Text] [Related]
37. IgNAR antibody: Structural features, diversity and applications.
Khalid Z; Chen Y; Yu D; Abbas M; Huan M; Naz Z; Mengist HM; Cao MJ; Jin T
Fish Shellfish Immunol; 2022 Feb; 121():467-477. PubMed ID: 35077867
[TBL] [Abstract][Full Text] [Related]
38. Construction of an artificially randomized IgNAR phage display library: screening of variable regions that bind to hen egg white lysozyme.
Ohtani M; Hikima J; Jung TS; Kondo H; Hirono I; Aoki T
Mar Biotechnol (NY); 2013 Feb; 15(1):56-62. PubMed ID: 22552958
[TBL] [Abstract][Full Text] [Related]
39. Shark IgNAR-derived binding domains as potential diagnostic and therapeutic agents.
Matz H; Dooley H
Dev Comp Immunol; 2019 Jan; 90():100-107. PubMed ID: 30236879
[TBL] [Abstract][Full Text] [Related]
40. Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development.
Ubah OC; Barelle CJ; Buschhaus MJ; Porter AJ
Curr Pharm Des; 2016; 22(43):6519-6526. PubMed ID: 27604606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
